Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASHLAND INC.ASH · Entity 4139 | Sr VP & Gen Mgr, Personal Care | February 03, 2023 | February 24, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASHLAND INC.
Report date February 03, 2023 · Filed February 24, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 440 |
Ending reported balance
After 2023-02-03 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2023-02-03 · Exercise / conversion · Acquired 2,022 · Balance 2,462 F1: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. Row 2 · 2023-02-03 · Disposition to issuer · Disposed 2,022 · Balance 440 Row 3 · 2023-02-03 · Exercise / conversion · Acquired 273 · Balance 713 F1: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. Row 4 · 2023-02-03 · Disposition to issuer · Disposed 273 · Balance 440 Row 5 · 2023-02-03 · Exercise / conversion · Acquired 2,757 · Balance 3,197 F1: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. Row 6 · 2023-02-03 · Disposition to issuer · Disposed 2,757 · Balance 440 |
| Restricted Stock EquivalentsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-02-03 · Exercise / conversion · Disposed 2,022 · Balance 0 F1: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F2: Reporting Person's 2020-2022 Performance Stock Equivalents converted to time-based cash settled RSUs based on performance of the 2020-2022 LTIP Plan and vests three years from the original grant. |
| Restricted Stock EquivalentsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-02-03 · Exercise / conversion · Disposed 273 · Balance 0 F1: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F3: Grant of cash-settled Restricted Stock Equivalents on February 3,2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The s hares in this grant vest in three equal annual installments beginning one year from the date of the grant, provided that the Reporting Person remains in continuous employment with the Issuer. |
| Restricted Stock EquivalentsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-02-03 · Exercise / conversion · Disposed 2,757 · Balance 0 F1: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F4: Grant of cash-settled Restricted Stock Equivalents on February 3, 2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One hundred percent of the shares awarded vested February 3, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash.
F2: Reporting Person's 2020-2022 Performance Stock Equivalents converted to time-based cash settled RSUs based on performance of the 2020-2022 LTIP Plan and vests three years from the original grant.
F3: Grant of cash-settled Restricted Stock Equivalents on February 3,2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The s hares in this grant vest in three equal annual installments beginning one year from the date of the grant, provided that the Reporting Person remains in continuous employment with the Issuer.
F4: Grant of cash-settled Restricted Stock Equivalents on February 3, 2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One hundred percent of the shares awarded vested February 3, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionRestricted Stock Equivalents · Derivative | 2,757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · derivative · entry 9 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F4 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents on February 3, 2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One hundred percent of the shares awarded vested February 3, 2023. F4 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents on February 3, 2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One hundred percent of the shares awarded vested February 3, 2023. Read SEC document |
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionRestricted Stock Equivalents · Derivative | 273 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · derivative · entry 8 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F3 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents on February 3,2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The s hares in this grant vest in three equal annual installments beginning one year from the date of the grant, provided that the Reporting Person remains in continuous employment with the Issuer. F3 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents on February 3,2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The s hares in this grant vest in three equal annual installments beginning one year from the date of the grant, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionRestricted Stock Equivalents · Derivative | 2,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · derivative · entry 7 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,022 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F2 · derivative.exercise_date: Reporting Person's 2020-2022 Performance Stock Equivalents converted to time-based cash settled RSUs based on performance of the 2020-2022 LTIP Plan and vests three years from the original grant. F2 · derivative.expiration_date: Reporting Person's 2020-2022 Performance Stock Equivalents converted to time-based cash settled RSUs based on performance of the 2020-2022 LTIP Plan and vests three years from the original grant. Read SEC document |
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Disposition to issuerCommon Stock | 2,757 | $105.31 | $290,339.67 |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · nonDerivative · entry 6 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440 Read SEC document |
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionCommon Stock | 2,757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · nonDerivative · entry 5 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. Read SEC document |
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Disposition to issuerCommon Stock | 273 | $105.31 | $28,749.63 |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · nonDerivative · entry 4 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440 Read SEC document |
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionCommon Stock | 273 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · nonDerivative · entry 3 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. Read SEC document |
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Disposition to issuerCommon Stock | 2,022 | $105.31 | $212,936.82 |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · nonDerivative · entry 2 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440 Read SEC document |
| February 03, 2023 Filed Feb 24, 2023 21:56 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionCommon Stock | 2,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007198 · form4.xml · nonDerivative · entry 1 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 13:52 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionRestricted Stock Units · Derivative | 827 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-026133 · form4.xml · derivative · entry 3 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,658 Underlying: Common Stock · 827 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F3 · derivative.exercise_date: Grant of Restricted Stock Units on November 18, 2021, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. F3 · derivative.expiration_date: Grant of Restricted Stock Units on November 18, 2021, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 13:52 UTC | ASHLAND INC. ASH · Entity 4139 | Tax withholdingCommon Stock | 387 | $111.80 | $43,266.60 |
DisclosureSEC source: 0001127602-22-026133 · form4.xml · nonDerivative · entry 2 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440 F1 · kind: Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units, acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 13:52 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionCommon Stock | 827 | $111.88 | $92,524.76 |
DisclosureSEC source: 0001127602-22-026133 · form4.xml · nonDerivative · entry 1 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 13:52 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 2,391 | $110.74 | $264,779.34 |
DisclosureSEC source: 0001127602-22-026133 · form4.xml · derivative · entry 4 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,913 Underlying: Common Stock · 2,391 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F4 · derivative.exercise_date: Grant of Restricted Stock Units on November 17, 2022, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. F4 · derivative.expiration_date: Grant of Restricted Stock Units on November 17, 2022, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 13:47 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionRestricted Stock Equivalents · Derivative | 269.391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-003300 · form4.xml · derivative · entry 3 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269.388 Underlying: Common Stock · 269.391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F2 · derivative.exercise_date: Grant of Restricted Stock Equivalents on February 3, 2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. F2 · derivative.expiration_date: Grant of Restricted Stock Equivalents on February 3, 2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 13:47 UTC | ASHLAND INC. ASH · Entity 4139 | Disposition to issuerCommon Stock | 269.391 | $96.03 | $25,869.62 |
DisclosureSEC source: 0001127602-22-003300 · form4.xml · nonDerivative · entry 2 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 13:47 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionCommon Stock | 269.391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-003300 · form4.xml · nonDerivative · entry 1 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269.391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. Read SEC document |
| November 18, 2021 Filed Nov 29, 2021 15:22 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 2,453 | $106.33 | $260,827.49 |
DisclosureSEC source: 0001127602-21-029761 · form4.xml · derivative · entry 1 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,453 Underlying: Common Stock · 2,453 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments, beginning one year after date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. F2 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments, beginning one year after date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 17:30 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionRestricted Stock Equivalents · Derivative | 621.995 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-029730 · form4.xml · derivative · entry 3 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,246 Underlying: Common Stock · 621.995 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One third of the restricted stock equivalents awarded on November 17, 2020 vested. F2 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One third of the restricted stock equivalents awarded on November 17, 2020 vested. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 17:30 UTC | ASHLAND INC. ASH · Entity 4139 | Disposition to issuerCommon Stock | 621.995 | $106.93 | $66,509.93 |
DisclosureSEC source: 0001127602-21-029730 · form4.xml · nonDerivative · entry 2 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 17:30 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionCommon Stock | 621.995 | $106.93 | $66,509.93 |
DisclosureSEC source: 0001127602-21-029730 · form4.xml · nonDerivative · entry 1 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621.995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 17:02 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionRestricted Stock Equivalents · Derivative | 265.998 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-004217 · form4.xml · derivative · entry 3 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,735.002 Underlying: Common Stock · 265.998 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. F2 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One third of the restricted stock equivalents awarded on February 3, 2020 vested. F2 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One third of the restricted stock equivalents awarded on February 3, 2020 vested. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 17:02 UTC | ASHLAND INC. ASH · Entity 4139 | Disposition to issuerCommon Stock | 265.998 | $85.66 | $22,785.39 |
DisclosureSEC source: 0001127602-21-004217 · form4.xml · nonDerivative · entry 2 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 17:02 UTC | ASHLAND INC. ASH · Entity 4139 | Exercise / conversionCommon Stock | 265.998 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-004217 · form4.xml · nonDerivative · entry 1 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265.998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 17:12 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Equivalents · Derivative | 1,850 | $79.40 | $146,890.00 |
DisclosureSEC source: 0001127602-20-029480 · form4.xml · derivative · entry 1 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,001 Underlying: Common Stock · 1,850 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments, beginning one year after date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. F2 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments, beginning one year after date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 15:24 UTC | ASHLAND INC. ASH · Entity 4139 | GrantStock Appreciation Right · Derivative | 4,207 | $75.57 Strike: $75.57 | $317,922.99 |
DisclosureSEC source: 0001127602-20-003728 · form4.xml · derivative · entry 4 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,207 Underlying: Common Stock · 4,207 shares Expires 2030-02-03 F5 · derivative.exercise_date: Stock Appreciation Right granted pursuant to Ashland's incentive plan which vests in three installments: 50% on February 3, 2021, 25% on February 3, 2022, and the remaining 25% on February 3, 2023. This grant will expire ten years from the date of grant. F5 · derivative.expiration_date: Stock Appreciation Right granted pursuant to Ashland's incentive plan which vests in three installments: 50% on February 3, 2021, 25% on February 3, 2022, and the remaining 25% on February 3, 2023. This grant will expire ten years from the date of grant. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 15:24 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Equivalents · Derivative | 2,647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-003728 · form4.xml · derivative · entry 3 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,647 Underlying: Common Stock · 2,647 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F4 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest on February 3, 2024, provided that the Reporting Person remains in continuous employment with the Issuer. F4 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest on February 3, 2024, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 15:24 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Equivalents · Derivative | 2,647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-003728 · form4.xml · derivative · entry 2 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,647 Underlying: Common Stock · 2,647 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F3 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest on February 3, 2023, provided that the Reporting Person remains in continuous employment with the Issuer. F3 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest on February 3, 2023, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 15:24 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Equivalents · Derivative | 786 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-003728 · form4.xml · derivative · entry 1 WANG XIAOLAN · CIK 0001801776 · Sr VP & Gen Mgr, Personal Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786 Underlying: Common Stock · 786 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F1 · price: Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments, beginning one year after date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. F2 · derivative.expiration_date: Grant of cash-settled Restricted Stock Equivalents, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments, beginning one year after date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.